Evaluation of bone density measurement in type 2 diabetic postmenopausal women with hypertension and hyperlipidemia

• Published in: Journal of menopausal medicine 2015, 21(1), , pp.36-40
• Main Authors: Caglayan, Emel Kiyak, Engin-Ustun, Yaprak, Sari, Nagihan, Karacavus, Seyhan, Seckin, Levent, Kara, Mustafa
• Format: Article
• Language: English
• Subjects: Original; 산부인과학
• ISSN: 2288-6478; 2288-6761
• DOI: 10.6118/jmm.2015.21.1.36

The aim of the study was to compare bone mineral density (BMD) in healthy postmenopausal women to BMD in type 2 diabetic hypertensive postmenopausal women with hyperlipidemia. Fifty type 2 diabetic and hypertensive postmenopausal women with hyperlipidemia and 51 age and body mass index (BMI) matched healthy postmenopausal women were included. Lumbar spine and femoral neck BMD were noted in both groups. BMD was measured using dual energy X-ray absorptiometry (DXA). Serum alkaline phosphatase (ALP), calcium and phosphorous were also measured. Pearson correlation coefficients were used to establish the relationship between various clinical characteristics. There were no significant differences between two groups in respect to lumbar and vertebral BMD values, age, BMI, gravidity, parity. Serum cholesterol and fasting glucose levels were significantly different between each groups (P = 0.0001, P = 0.002). We found that, accompanying chronic diseases such as diabetes, hypertension and hyperlipidemia don't affect the BMD measurements at postmenopausal period. So these postmenopausal women don't have excess risk regarding osteoporosis.